(Q35164785)

6 August 2017

1 reference

title

Receptor induction and targeted drug delivery: a new antileukaemia strategy (English)

1 reference

6 August 2017

1 reference

Manohar Ratnam

1

1 reference

6 August 2017

Hong Hao

2

1 reference

6 August 2017

Xuan Zheng

3

1 reference

6 August 2017

Hui Wang

4

1 reference

6 August 2017

Huiling Qi

5

1 reference

6 August 2017

Robert Lee

6

1 reference

6 August 2017

Xing Pan

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Biological Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

563-574

1 reference

Modulation of multidrug resistance (MDR) in hematological malignancies

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Retinoids in chemoprevention and differentiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Cell surface receptor-targeted therapy of acute myeloid leukemia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Structure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Preferred Sites of Glycosylphosphatidylinositol Modification in Folate Receptors and Constraints in the Primary Structure of the Hydrophobic Portion of the Signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Clustering of GPI-anchored folate receptor independent of both cross-linking and association with caveolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Expression levels of functional folate receptors alpha and beta are related to the number of N-glycosylated sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Recognition of the carboxyl-terminal signal for GPI modification requires translocation of its hydrophobic domain across the ER membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Overexpression of folate binding protein in ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Folate-mediated targeting: from diagnostics to drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Folate-mediated delivery of macromolecular anticancer therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Targeted drug delivery via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Intracellular delivery of nanometric DNA particles via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Folate-PEG-folate-graft-polyethylenimine-based gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Bispecific antibody targeted T cell therapy of ovarian cancer: clinical results and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Dual-specific T cells combine proliferation and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Evidence for segregation of heterologous GPI-anchored proteins into separate lipid rafts within the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Pegylated doxorubicin for primary cutaneous T-cell lymphoma: a report on ten patients with follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Effect of liposomes on P-glycoprotein function in multidrug resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Anti-HER2 immunoliposomes for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Affinity liposomes in vivo: factors influencing target accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

Approaches to implement bispecific antibody treatment of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.563

21 January 2018

Identifiers

DOI

10.1517/14712598.3.4.563

1 reference

6 August 2017

1 reference